•   
  •   
  •   

US California says it will independently review coronavirus vaccine

02:00  20 october  2020
02:00  20 october  2020 Source:   reuters.com

AstraZeneca Pausing Vaccine Trial Over Participant Illness a Good Thing, Experts Say

  AstraZeneca Pausing Vaccine Trial Over Participant Illness a Good Thing, Experts Say Dr. James Gill of Warwick Medical School said the decision "should be championed as good science and great transparency."The study was halted following a "standard" review process, so safety data could be investigated, a spokesperson for the COVID-19 Vaccine Team at the Oxford Vaccine Centre told Newsweek in a statement.

An American biotech company says it created a coronavirus vaccine three hours after getting access to the virus' genetic sequence on Jan. 9, and now scientists are racing to get the vaccine on the market in record time.

Coronavirus Vaccine Tracker. By Jonathan Corum, Sui-Lee Wee and Carl ZimmerUpdated October 16, 2020. Experts say the rushed process has serious risks. APPROVAL: Regulators in each country review the It would become Sanofi’s second Covid-19 vaccine candidate in clinical trials, along with their It ’s hard to independently determine how much truth there is in the claim from the isolated

By Mimi Dwyer

a hand holding a blue toothbrush: FILE PHOTO: A woman holds a small bottle labeled with a 'Vaccine COVID-19' sticker and a medical syringe in this illustration © Reuters/Dado Ruvic FILE PHOTO: A woman holds a small bottle labeled with a 'Vaccine COVID-19' sticker and a medical syringe in this illustration

LOS ANGELES (Reuters) - A California panel of experts will independently review the safety of new coronavirus vaccines and initial plans for distribution, Governor Gavin Newsom said on Monday.

The 11-person panel specializing in topics such as epidemiology, biostatistics, and infectious disease will review any vaccine approved by the Food and Drug Administration before it is distributed to state residents, Newsom told a news conference.

China Covid-19 vaccine: Inside the company at the forefront of China's push to develop a coronavirus vaccine

  China Covid-19 vaccine: Inside the company at the forefront of China's push to develop a coronavirus vaccine Inside the white, sterile walls of a new building on the southern outskirts of Beijing, two employees donning masks and rubber gloves are busy pipetting a clear, colorless liquid into rows of small vials. © NICOLAS ASFOURI/AFP/AFP via Getty Images In this picture taken on April 29, 2020, an engineer shows an experimental vaccine for the COVID-19 coronavirus that was tested at the Quality Control Laboratory at the Sinovac Biotech facilities in Beijing.

The WHO has said it doesn't expect widespread vaccinations against coronavirus until mid-2021. How are vaccines tested? In the pre-clinical stage of In phase 1 of clinical testing, the vaccine is given to a small group of people to determine whether it is safe and to learn more about the immune

Johnson & Johnson has temporarily halted its coronavirus vaccine trial after a trial participant contracted an “unexplained illness,” the company The pharma firm’s 60,000-patient vaccine study was paused due to an adverse reaction in a volunteer, J&J confirmed to Stat News on Monday, citing

"These are top health experts that will independently review any FDA-approved vaccines," he said. "We will do our own independently reviewed process with our world-class experts that just happen to live here in the state of California."

The U.S. government's efforts to speed development of a COVID-19 vaccine - and promises by U.S. President Donald Trump that one could be available prior to the Nov. 3 presidential election - has led to concerns of political interference in the regulatory process at the expense of safety. The FDA has vowed to ensure the safety of COVID-19 vaccines before approving them.

New York will conduct a similar review of federally approved vaccines, Governor Andrew Cuomo said last month.

The California panel will review the vaccine's safety regardless of the outcome of the presidential election, Newsom said.

Newsom cautioned that even under the most optimistic projections a vaccine will not be widely available to California residents before next year.

"Don't anticipate or expect that you can go down to the local pharmacy any time in this calendar year and likely get a vaccination," he said.

The state will prioritize healthcare workers and other first responders initially in distribution.

(Reporting by Mimi Dwyer; editing by Bill Tarrant and Sam Holmes)

The FDA and CDC Promised Transparency in the Vaccine Approval Process. Here's How Congress Can Hold Them to It .
Senators Maggie Hassan and Lisa Murkowski introduced the SAVE Act to ensure that the CDC and FDA follow through with the transparency they committed to around vaccine approval process.While we all hope to get potential vaccines reviewed, produced and distributed as quickly as possible, we can’t sacrifice safety and efficacy for speed. It is also critically important that the public has confidence in the federal government’s vaccine review process, which includes assurances that the Food and Drug Administration (FDA) has followed the necessary protocols to ensure vaccine safety and effectiveness.

usr: 0
This is interesting!